Kiromic Biopharma Inc.

24/04/2024 | Press release | Distributed by Public on 24/04/2024 19:09

Kiromic BioPharma Reports Consistent Favorable Safety, Tolerability, and Efficacy in Deltacel-01 Clinical Trial First Three Patients